SCHEMBL14725636

SCHEMBL14725636

c1cncc(-c2ccc(-c3cc4cc5c(cc(-c6ccc(-c7cccnc7)cc6)c6ccc7c8ccccc8oc7c65)cc4c4c3ccc3c5ccccc5oc34)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.46
KDM4E B2RXH2 4/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
PRKDC P78527 1/20 0.40
CYP1B1 Q16678 1/20 0.40
HIPK2 Q9H2X6 1/20 0.39
CYP19A1 P11511 3/20 0.39
CYP17A1 P05093 1/20 0.39
CYP11B2 P19099 1/20 0.39
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 4/20 0.39
MEN1 O00255 2/20 0.39
DHODH Q02127 1/20 0.37
GPR84 Q9NQS5 1/20 0.37
PGR P06401 1/20 0.37
MAPT P10636 3/20 0.36
ALOX5 P09917 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725652 0.94 CYP11B1 (0.52) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL14725718 0.91 CYP11B1 (0.43) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL16472826 0.87 CYP11B1 (0.48) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL16472675 0.87 CYP11B1 (0.45) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL14725727 0.84 CYP11B1 (0.49) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL16472885 0.84 CYP11B1 (0.43) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL16472927 0.83 CYP11B1 (0.43) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL15461843 0.81 CYP11B1 (0.48) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL16472744 0.81 CYP11B1 (0.40) CYP11B1KDM4EKMT2ACYP1A1CYP1A2
SCHEMBL15446949 0.81 ALOX5 (0.45) CYP11B1KDM4EKMT2ACYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 CYP11B1 887/4885KDM4E 1981/4885KMT2A 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.